University Hospital Eppendorf (UKE) head of infectiology Marylyn Addo attends a news conference on the start of a study with the Ebola drug Remdesivir with particularly severely ill patients at the UKE in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS